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The homeobox gene Gsx2 (formerly Gsh2) is known
to be required for striatal and olfactory bulb neuro-
genesis; however, its specific role in the specification
of these two neuronal subtypes remains unclear. To
address this, we have employed a temporally regu-
lated gain-of-function approach in transgenic mice
and found that misexpression ofGsx2 at early stages
of telencephalic neurogenesis favors the specifica-
tion of striatal projection neuron identity over that
of olfactory bulb interneurons. In contrast, delayed
activation of the Gsx2 transgene until later stages
exclusively promotes olfactory bulb interneuron
identity. In a complementary approach, we have con-
ditionally inactivated Gsx2 in a temporally progres-
sive manner. Unlike germline Gsx2 mutants, which
exhibit severe alterations in both striatal and olfac-
tory bulb neurogenesis at birth, the conditional
mutants exhibited defects restricted to olfactory
bulb interneurons. These results demonstrate that
Gsx2 specifies striatal projection neuron and olfac-
tory bulb interneuron identity at distinct time points
during telencephalic neurogenesis.
INTRODUCTION
The telencephalon represents the largest and most complex
region of the mammalian brain. This region is charged with the
task of complex neural processing that controls all cognitive
processes and purposeful actions. Accordingly, the telenceph-
alon exhibits the greatest amount of neuronal diversity of any
portion of the CNS. Previously, many groups have focused on
the generation of neuronal diversity within the telencephalon (re-
viewed in Marin and Rubenstein, 2003). While neuronal progen-
itors in the dorsal telencephalon (also termed the pallium) are
thought to give rise to the excitatory cortical projection neurons,
the vast majority of cortical interneurons originate from progen-
itor domains located in the ventral telencephalon. Althoughlimited pallial contributions to ventral telencephalic neuronal
subtypes have recently been proposed (Willaime-Morawek
et al., 2006; Kohwi et al., 2007; Young et al., 2007; Willaime-Mor-
awek and van der Kooy, 2008), most of the neuronal diversity
found in the mature telencephalon appears to derive from
progenitor cells positioned in the ventral telencephalon during
embryogenesis (Rallu et al., 2002; Campbell, 2003; Marin and
Rubenstein, 2003).
The lateral ganglionic eminence (LGE) represents one such
ventral telencephalic progenitor region, which has been shown
to generate the projection neurons of the striatum as well as
interneurons in the olfactory bulb (Deacon et al., 1994; Olsson
et al., 1995, 1998; Wichterle et al., 2001). Despite the fact that
both striatal projection neurons and olfactory bulb interneurons
derive from the LGE, they exhibit different temporal profiles of
neurogenesis in the rodent; the striatal neurons are generated
almost exclusively at embryonic time points, whereas the olfac-
tory bulb interneurons begin their genesis at later embryonic
time points and continue into the early postnatal period, when
the vast majority are born (Hinds, 1968; Bayer and Altman,
2004; Batista-Brito et al., 2008). Recent studies have suggested
that these two neuronal subtypes derive from separate progen-
itors located in distinct regions within the LGE, termed the
ventral (v)LGE and dorsal (d)LGE, respectively (Yun et al.,
2001, 2003; Stenman et al., 2003a; Waclaw et al., 2006). Yun
et al. (2001) first described these two LGE subdivisions based
on gene expression patterns at midgestation stages. The
dLGE was characterized by high levels of Gsx2 and Er81 in
progenitors of the ventricular zone (VZ), while the vLGE lacks
Er81 expression and displays lower levels of Gsx2. These
compartments can also be identified in the subventricular zone
(SVZ) and mantle regions of the LGE. Islet1 (Isl1) is expressed
in the vLGE SVZ and transiently in its striatal projection neuron
derivatives whereas Er81 and Sp8 mark the dLGE SVZ and
remain expressed in distinct subtypes of olfactory bulb interneu-
rons (Stenman et al., 2003a; Waclaw et al., 2006; Allen et al.,
2007; Saino-Saito et al., 2007). These two LGE progenitor
domains are bordered dorsally by the ventral pallium (marked
by Dbx1) and ventrally by the interganglionic sulcus, which is
marked by Nkx6.2 expression (Stenman et al., 2003b). Dbx1-
and Nkx6.2-expressing progenitors have been shown toNeuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 451
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Temporal Specification of Neuronal Fate in the LGEcontribute to amygdalar projection neurons and cortical inter-
neurons, respectively (Hirata et al., 2009; Sousa et al., 2009).
Correct patterning of the vLGE and dLGE requires Gsx2 and
Pax6 gene function. The loss of the pallial regulator Pax6 results
in a dorsal expansion of dLGE markers (Toresson et al., 2000;
Stoykova et al., 2000; Yun et al., 2001; Stenman et al., 2003a;
Kroll and O’Leary, 2005; Waclaw et al., 2006), suggesting a
role for the paired homeodomain factor in repressing dLGE iden-
tity within pallial progenitors. In the absence of Gsx2, the vLGE
and dLGE as well as their derivatives, the striatal projection
neurons and olfactory bulb interneurons, are severely reduced
(Corbin et al., 2000; Toresson et al., 2000; Toresson and Camp-
bell, 2001; Yun et al., 2001, 2003; Stenman et al., 2003a; Waclaw
et al., 2004, 2006). The specific role of Gsx2 in patterning and
specification of the vLGE and dLGE, however, remains some-
what unclear. So far, no evidence has been provided to support
a role for Gsx2 in directly ventralizing telencephalic progenitors
(Corbin et al., 2000). Loss-of-function studies, however, sug-
gested that Gsx2 indirectly controls LGE specification by repres-
sing the expression of dorsal telencephalic regulators such as
Pax6 in LGE progenitors (Corbin et al., 2000; Toresson et al.,
2000; Yun et al., 2001). This appears to be a conserved function
of Gsx2 since the Drosophila homolog Ind (intermediate neuro-
blasts defective) has also been shown to repress eyeless, the
Pax6 homolog, in fly CNS development (Von Ohlen et al., 2007).
We have reexamined the role of Gsx2 in LGE specification
using conditional gain-of-function and loss-of-function
approaches in mice. These models afforded the analysis of
temporally distinct roles for Gsx2 in the specification of vLGE
and dLGE. Our results demonstrate that Gsx2 can directly ven-
tralize pallial progenitors and, depending on the developmental
stage, specifies different neuronal fates. In particular, at early
stages of telencephalic development, Gsx2 is necessary and
sufficient to correctly specify the vLGE and its major derivatives,
the striatal projection neurons; however, at later stages, high
levels of Gsx2 specify LGE progenitors toward dLGE fates
including olfactory bulb interneurons.
RESULTS
Dynamic Expression of Gsx2 in LGE Progenitors
The homeobox gene Gsx2 is first expressed in progenitors of the
presumptive LGE between embryonic days (E)9 and E10 (Tores-
son et al., 2000; Corbin et al., 2003). Initially, this factor is ex-
pressed at high levels in cells throughout the presumptive LGE,
with an apparent ventral-to-dorsal gradient in Gsx2-positive
cell numbers (Figure 1A). Gsx2-positive cells are also scattered
somewhat uniformly throughout the adjacent medial ganglionic
eminence (MGE), as marked by Nkx2.1 expression (Figure 1A).
To detect Isl1, we used an Isl1/2 antibody (Tsuchida et al.,
1994). Although Isl1-expressing cells are found in ventral telen-
cephalon throughout development, the closely related Isl2 is
not expressed in this brain region (Wang and Liu, 2001). At early
stages (e.g., E11), Isl1 cells appear to emerge from a broad
portion of the presumptive LGE (Figure 1B); however, Sp8 is
seen in scattered cells adjacent to the dorsal-most portion of
the LGE (Figure 1B). At later embryonic stages (e.g., E12.5
onward), Gsx2 exhibits a clear graded pattern of expression,452 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.with low levels found in cells located ventrally and the highest
levels confined to those in the most dorsal portion of the LGE
(Figures 1C and 1H). Previously, Yun et al. (2001) used this
high level of Gsx2 along with other markers to define the dLGE.
Indeed, Sp8-positive cells that mark the dLGE SVZ adjoin the
high-level Gsx2-expressing cells in the VZ (Figure 1D), while
the Isl1 (vLGE) SVZ cells are positioned adjacent to the low-level
Gsx2-expressing cells of the VZ (Figure 1E). This dynamic
expression pattern might suggest that high levels of Gsx2, at
early stages of forebrain development (i.e., E9–E11), are capable
of specifying both vLGE and dLGE identity with a predominance
for vLGE and thus striatal projection neuron fate. At later stages
(i.e., E12 onward), however, high levels of Gsx2 in LGE progen-
itors may primarily promote dLGE fates, including olfactory
bulb interneurons.
Conditional Misexpression of Gsx2
In order to test this temporal specification model, we developed
a doxycyclin (Dox)-regulated binary transgenic system for the
spatially and temporally controlled misexpression of Gsx2 in
the embryonic mouse telencephalon (Figure 1F). We generated
tetO-Gsx2-IRES-EGFP (IE) mice to use with Foxg1tTA/+ mice
(Hanashima et al., 2002) to drive expression of Gsx2 in the
embryonic telencephalon. Foxg1tTA/+;tetO-Gsx2-IE embryos ex-
pressed EGFP throughout the telencephalon (Figure 1G) and this
expression was detected as early as E9.5 (data not shown). In
addition to EGFP, Gsx2 was also expressed in telencephalic
progenitors rather uniformly both in the ventral and dorsal telen-
cephalon (Figures 1I and 1J). Multiple lines of tetO-Gsx2-IE mice
were identified that were responsive to Foxg1tTA/+, with broad
telencephalic expression of the transgenes. While most of these
lines responded robustly to tTA, the tetO-Gsx2-IE line, which
showed the most reliable and robust response with no leaky
expression of the transgenes, was used in the present study.
All controls shown are tetO-Gsx2-IE single transgenic embryos;
however, the Foxg1tTA/+ single transgenic embryos were iden-
tical with respect to the markers examined despite the fact
that they only have one functional allele of Foxg1 (data not
shown).
As mentioned above, EGFP could be detected as early as E9.5
in the Foxg1tTA/+;tetO-Gsx2-IE embryos, and thus these animals
represented an early misexpression of Gsx2 throughout the
telencephalon. To determine whether ectopic Gsx2 could alter
dorsal-ventral patterning, we examined the expression of the
ventral telencephalic regulators Ascl1 (Mash1) and Dlx proteins
at E12.5 (Anderson et al., 1997; Casarosa et al., 1999; Horton
et al., 1999). Both Ascl1 (Figure 2B) and Dlx proteins (Figure 2E)
were found ectopically expressed (as marked by EGFP) within
the dorsal telencephalon (Figures 2C and 2F). Ascl1 was upregu-
lated in the VZ of the pallium while the Dlx proteins were most
highly expressed in the SVZ of the pallium, similar to their
patterns of expression in the ventral telencephalon (Figures 2A
and 2D). In contrast, the pallial regulators Pax6 (Figures 2H
and 2I) and Tbr1 (Figure 2K and 2L) were both reduced in the
dorsal telencephalon as compared to levels in the control
embryos (Figures 2G and 2J). All Foxg1tTA/+;tetO-Gsx2-IE
embryos examined showed similar expression patterns of
Ascl1, Dlx, Pax6, and Tbr1 proteins, even at later stages (i.e.,
Neuron
Temporal Specification of Neuronal Fate in the LGEE14.5 and E15.5); however, analysis of the double transgenic
brains after E15.5 was not performed as the morphology
became very disrupted (Figure S1 available online). We never
observed ectopic expression of the MGE marker Nkx2.1 and,
in fact, found that it was reduced or missing in all the double
transgenic embryos examined (Figure S1H). These findings
therefore suggest that early misexpression of Gsx2 specifically
promotes LGE identity within pallial progenitors.
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(A) Gsx2 (green) and Nkx2.1 (red) expression in E11 coronal
section of the telencephalon. (B) Overlay of adjacent E11
coronal sections stained for Isl1 (red) and Sp8 (green). (C)
Gsx2 expression in E14.5 LGE showing a ventral-low to
dorsal-high gradient with dLGE and vLGE separated by dotted
line (C–E). (D) Overlay of adjacent sections stained with Gsx2
(red) and Sp8 (green). Sp8 cells are adjoining the high Gsx2
domain (i.e., dLGE). (E) Overlay of adjacent sections stained
with Gsx2 (red) and Isl1 (green). Isl1-positive cells are neigh-
boring the low Gsx2 domain (i.e., vLGE). (F) Breeding strategy
to express Gsx2 throughout the telencephalon. (G) Double
transgenic embryo (Foxg1tTA/+;tetO-Gsx2-IE) expressing
EGFP throughout the E14 telencephalon. (H) Gsx2 expression
in control (tetO-Gsx2-IE) embryo at E12.5. (I) Gsx2 is ex-
pressed throughout the telencephalon in an E12.5 double
transgenic embryo. (J) Merged image of Gsx2 and EGFP in
double transgenic embryo.
To study the role of Gsx2 in the specification of
the vLGE versus the dLGE, we examined Isl1 and
Sp8 expression, respectively. Interestingly, the
Foxg1tTA/+;tet-O-Gsx2-IE embryos were found to
express Isl1 throughout the dorsal-ventral aspect
of the telencephalon both at E14.5 (Figure 2N) and
at E15.5 (Figure S1F). Conversely, only scattered
Sp8 cells were detected in the pallium at either stage
(Figures 2P and S1G). In all cases, the normal dLGE
expression domain of Sp8 in the ventral telenceph-
alon of double transgenic embryos was severely
reduced. Taken together with the findings above,
our data indicate that early (i.e., from E9.5 onward)
misexpression of Gsx2 favors vLGE specification
within the majority of telencephalic progenitors.
The widespread overexpression of Gsx2 (and
EGFP) observed in the Foxg1tTA/+;tet-O-Gsx2-IE
embryos shown in Figures 1 and 2 does not allow
us to conclude whether Gsx2 regulates telence-
phalic gene expression in a cell autonomous
manner or if it induces extrinsic factors, which
subsequently control the patterns of gene expres-
sion in adjacent progenitors. In this respect, on
very rare occasions, we obtained double trans-
genic embryos that displayed mosaic transgene
expression (Figures S2A and S2B). EGFP and
Gsx2 were expressed in what appeared as radial
clones, and specifically within these clones Pax6
was repressed (Figures S2E and S2F) while Ascl1
and Dlx were cell-autonomously induced (Figures
S2C and S2D). As was the case with the uniformly overexpress-
ing embryos (see Figure 2), the mosaic embryos also showed
a preferential induction of Isl1 over Sp8 in the EGFP-positive
cells (Figures S2G and S2H), indicating that early misexpression
of Gsx2 favors vLGE specification within telencephalic progeni-
tors in a cell autonomous manner.
To examine a later role for Gsx2 in the specification of vLGE
and dLGE, we made use of the fact that Dox can repressNeuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 453
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Figure 2. Misexpression of Gsx2 Results in Increased Expression of Ventral Telencephalic Markers throughout the Pallium
(A–L) Coronal sections through the telencephalon of E12.5 control (tetO-Gsx2-IE) (A, D, G, and J) and double transgenic (Foxg1tTA/+;tetO-Gsx2-IE) (B, C, E, F, H, I,
K, and L) embryos. The ventral markers Ascl1 and Dlx proteins are induced in EGFP-positive cells in the pallium of double transgenic embryos (compare B and C
to A and E and F to D). The pallial markers Pax6 and Tbr1 are severely reduced in double transgenic embryos (H and K) compared to control embryos (G and J).
Note the EGFP transgene is highly expressed in Pax6- and Tbr1-negative regions (I and L).
(M–P) Coronal sections of E14.5 control (M and O) and double transgenic (N and P) embryos. The vLGE marker Isl1 is ectopically expressed throughout the telen-
cephalon of double transgenic embryos (compare N to M), while the dLGE marker Sp8 is only observed in scattered cells within the pallium (P) and is reduced in
the normal expression domain of the dLGE.transgene expression in the Foxg1tTA/+;tetO-Gsx2-IE embryos
(Figure 1F). By adding Dox (0.02 mg/ml) in the drinking water
of the pregnant dams from E7 to E9, we found that transgene
expression was repressed until around E12.5 (Figure 3F), and
not until E13.5 was the transgene expressed throughout the
telencephalon (Figure 3I), in a manner similar to endogenous
Foxg1. As mentioned above, when no Dox is administered the
transgene is first detected at E9.5, with robust expression
between E10.5 and E13.5 (Figures 3B, 3E, and 3H). The tetO-
Gsx2-IE embryos served as controls for these studies and do
not show ectopic expression at any stage examined (Figures454 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.3A, 3D, and 3G). At E13.5, the level of Gsx2 and EGFP expres-
sion is considerably lower in the Dox-treated embryos (Figures
3I, 3L, and 3M) than in the double transgenic embryos that
were not administered Dox (Figures 3H, 3J, and 3K). By E15.5,
however, the Gsx2 transgene appears to be expressed at similar
levels to that in non-Dox-treated embryos (Figures S1E and S1I).
A dramatic improvement in the morphology of brains was
observed at later stages in the Dox-treated double transgenic
embryos (Figures 4 and S1I–S1L) as compared to the untreated
double transgenic embryos (Figures 2N and 2P and Figures
S1E–S1H).
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Temporal Specification of Neuronal Fate in the LGEConcomitant with the induction of Gsx2 and EGFP around
E13.5 in the Dox-treated Foxg1tTA/+;tetO-Gsx2-IE embryos, we
observed an upregulation of Ascl1 and Dlx proteins in the pallium
(data not shown). Tbr1 expression in the Dox-treated double
transgenics at E13.5 was only minimally reduced from the control
embryos (Figures 4A and 4F), unlike the case in non-Dox-treated
embryos (i.e., early misexpression of Gsx2) (Figures 2J and 2K).
At E15.5, the domain of Tbr1 expression in Dox-treated embryos
is not increased from that seen 2 days earlier (compare Figure 4G
with Figure 4F), suggesting that the production of these cells
ceases subsequent to Gsx2 misexpression. In fact, many breaks
in the Tbr1 expression domain were evident in the Foxg1tTA/
+;tetO-Gsx2-IE embryos and in each case, these Tbr1-negative
areas were found to express the EGFP and Gsx2 transgenes at
high levels (see inset in Figure 4G). Again, the areas misexpress-
ing Gsx2 and EGFP were found to be Ascl1 and Dlx expressing
(data not shown). As was the case in the early misexpression
embryos, no ectopic Nkx2.1 was detected. However, in the
Dox-treated double transgenic (i.e., delayed misexpression)
embryos, much more Nkx2.1 expression remained in the MGE
region as compared to their early-misexpression (non-Dox-
treated) counterparts (Figure S1L). Thus it appears that even
tetO-Gsx2-IE 
(control)
Foxg1tTA; tetO-Gsx2-IE 
no Dox Dox E7-9
Foxg1tTA; tetO-Gsx2-IE 
no Dox
Foxg1tTA; tetO-Gsx2-IE 
Dox E7-9
J K L M
Gsx2 Gsx2EGFP EGFP
E13.5
Figure 3. Temporal Control of Gsx2 Transgene
Expression using Doxycycline
(A–I) EGFP expression in the heads of control (tetO-Gsx2-
IE) (A, D, and G) and double transgenic (Foxg1tTA/+;tetO-
Gsx2-IE) embryos that either did not receive Dox (B, E,
and H) or were treated with Dox from E7–E9 (C, F, and I).
Double transgenic embryos that were not treated with
Dox exhibit EGFP expression in the telencephalon at
E10.5 (B), E12.5 (E), and E13.5 (H). Those treated with
Dox from E7–E9 exhibit a delay in transgene activation
as observed by minimal EGFP expression detected at
E11.5 (C) and a progressive increase in EGFP expression
at E12.5 (F) and E13.5 (I). Control embryos do not express
EGFP and are used for comparison as background fluo-
rescence levels (A, D, and G).
(J–M) Representative coronal sections of double trans-
genic embryos at E13.5 with no Dox treatment (J and K)
and Dox treatment from E7–E9 (L and M). Images were
taken at the same exposure. Note that Gsx2 and EGFP
are expressed much more highly in the non-Dox-treated
embryos (J and K) as compared to the Dox-treated
embryos (L and M).
when Gsx2 is expressed in progenitors of the
pallium from E13.5, it is capable of respecifying
them toward LGE fates.
To determine if the delayed misexpression of
Gsx2 differentially regulates the specification of
the vLGE versus the dLGE, we examined the
expression of Isl1 and Sp8, respectively. At
E15.5, Dox-treated embryos showed a dramatic
reduction in the domain of Isl1 expression
(Figure S1J) and concomitant expansion both
ventrally and dorsally of Sp8 expression
(Figure S1K). This was opposite to the trend
observed in the double transgenic embryos
that were not Dox treated (i.e., early misexpres-
sion; Figures S1F and S1G), despite the fact that similar levels of
Gsx2 expression were observed in both Dox-treated and non-
Dox-treated embryos (Figures S1E and S1I). As mentioned
above, the Dox-treated Foxg1tTA/+;tetO-Gsx2-IE embryos
exhibit improved morphology at later stages, and we were thus
able to examine vLGE and dLGE development at E18.5. By
this stage, Isl1 marks the major vLGE derivative, i.e., the forming
striatal complex (Figure 4C). In the Dox-treated double trans-
genics, Isl1 expression and accordingly the size of the forming
striatum is greatly reduced (Figure 4H). Conversely, Sp8 expres-
sion is upregulated throughout the developing cerebral cortex,
suggestive of dLGE respecification (Figures 4I and 4J). Interest-
ingly, as seen at E15.5 in delayed misexpression embryos, Sp8
expression is expanded ventrally in the LGE also at E18.5. This
could indicate that vLGE cells have been respecified to a dLGE
identity by the delayed misexpression of Gsx2; however, it is
possible that selective proliferation of dLGE progenitors
accounts for the enlarged Sp8 expression domain. The
Foxg1tTA/+;tetO-Gsx2-IE brains (with or without Dox treatment)
do not form normal olfactory bulbs and therefore it is difficult
to fully assess olfactory bulb interneuron development in these
animals. We can conclude, however, that the specification ofNeuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 455
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Figure 4. Delayed Expression of the Gsx2 Transgene Results in an Expansion of the dLGE
Coronal sections of control (tetO-Gsx2-IE) (A–E) and double transgenic (Foxg1tTA/+;tetO-Gsx2-IE) (F–J) embryos treated with Dox from E7–E9. At E13.5, Tbr1
expression in double transgenic embryos is similar (albeit slightly reduced) to that of control embryos (compare F to A). By E15.5, however, Tbr1 expression
in double transgenic embryos is greatly reduced as compared to that in control embryos (compare G to B). Inset in (G) shows a merged image of Tbr1 expression
with complementary expression of EGFP from the transgene. Isl1 expression is severely reduced in the ventral telencephalon (i.e., forming striatum) and is not
expressed in the pallium of double transgenic embryos at E18.5 (compare H to C). Conversely, Sp8 expression is increased throughout the pallium (arrowheads in
I) and even expanded ventrally in the LGE (arrows in I) of double transgenic embryos, as compared to control embryos (D). Overlays of adjacent sections clearly
show the expansion of Sp8 (i.e., dLGE) into the normal Isl1 (i.e., vLGE) expression domain of the LGE (compare J to E).these dLGE derivatives is exclusively promoted by delayed
misexpression of Gsx2. In summary, early misexpression (i.e.,
E9–E10) of Gsx2 appears to favor vLGE specification while later
misexpression (i.e., E13 and onward) promotes dLGE specifica-
tion, apparently at the expense of the vLGE.
Conditional Mutagenesis of Gsx2
To complement the gain-of-function experiments described
above, we have taken a conditional loss-of-function approach
to study the temporal role of Gsx2 in the specification of LGE
fates. We generated a conditional mutant allele (Gsx2flox) by
engineering loxP sites flanking exon 2, which includes the entire
homeodomain (Figures 5A and S3). Gsx2flox/flox mice appear
normal and express wild-type levels of Gsx2 protein (data not
shown), suggesting the floxed allele acts in a manner similar to
that of the wild-type Gsx2 allele. To determine if our recombined
conditional allele produced a loss-of-function mutation of Gsx2,
we crossed Gsx2flox/+ mice with mice carrying an EIIA-cre trans-
gene (Lakso et al., 1996), which recombines in the germline, to
generate mice carrying a globally recombined allele (RA) of
Gsx2 (Gsx2RA/+). Gsx2RA/RA mutant embryos do not express
Gsx2 protein (Figure S3D). In addition, Gsx2RA/RA mutant
embryos displayed a phenotype in the telencephalon (data not
shown) identical to that of the previously described mutation of
Gsx2 (Szucsik et al., 1997; Corbin et al., 2000; Toresson et al.,
2000; Yun et al., 2001).
To conditionally inactivate Gsx2, we crossed Gsx2flox/flox mice
with mice that were double heterozygous for the floxed allele
(Gsx2flox/+) and a cre knockin to the Emx1 locus (Emx1cre/+) (Gor-
ski et al., 2002). The Emx1cre mice are widely used to recombine456 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.floxed genes in the dorsal telencephalon; however, these mice
also induce recombination in scattered cells of the LGE (see
Figure 1F in Gorski et al., 2002). Our initial plan was to use the
Emx1cre/+ mice to produce a mosaic inactivation of Gsx2 in the
LGE in order to study cell autonomous versus non-cell-autono-
mous requirements as a complement to our mosaic misexpres-
sion (Figure S2). Indeed, recombination of the ROSA26 reporter
(R) (Mao et al., 1999) was detected as early as E10.5 in the
presumptive LGE (insets in Figures 5B and 5C), and at that
stage Gsx2 showed a slight mosaic recombination pattern in
the conditional mutants (Emx1cre/+;Gsx2flox/flox;R26R) (compare
Figures 5C to 5B). A clear mosaic inactivation of Gsx2 within
the LGE was evident by E12.5 when nearly half of all Gsx2
staining was lost (compare Figures 5E to 5D, see also S4).
Surprisingly, however, by E18.5, nearly 80% (430.3 ± 6.7 versus
96.3 ± 3.9 cells/section, p < 0.001; n = 3) of Gsx2-expressing
cells were lost in the LGE of conditional mutants (Figure 5I)
compared to controls (Figure 5H). This finding is quite significant
because Emx1cre/+ mice have been largely characterized as
pallial specific for cre recombination (Gorski et al., 2002; Will-
aime-Morawek et al., 2006; Willaime-Morawek and van der
Kooy, 2008; Kohwi et al., 2007). Our data provide clear evidence
that Emx1cre induces recombination of the Gsx2 floxed allele in
the LGE beginning around E10.5. In addition, the recombination
is progressively more severe in the LGE later in development,
resulting in an extensive loss of Gsx2 protein expression at
perinatal stages.
Germline Gsx2 mutants display abnormalities in dorsal-ventral
patterning of the telencephalon as observed by a ventral expan-
sion of pallial regulators into the LGE and a concomitant
Neuron
Temporal Specification of Neuronal Fate in the LGEdownregulation of ventral telencephalic genes (Corbin et al.,
2000; Toresson et al., 2000; Toresson and Campbell, 2001;
Yun et al., 2001, 2003). As mentioned above, conditional deletion
of Gsx2 using Emx1cre/+ mice results in a mosaic loss of Gsx2
protein in the LGE at E12.5 (Figure 5E), which allows for the
assessment of the Gsx2 mutant phenotype in a partial wild-
type environment. To compare mutant cells to wild-type cells,
we crossed the R26R mouse onto our conditional mutant
breeding scheme (Gsx2flox/+;Emx1cre/+ 3 Gsx2flox/flox;R26R+/).
These experiments clearly revealed that b-gal expression from
the R26R mouse underrepresents cre recombination in the
LGE because the reduction in Gsx2 protein expression in condi-
tional mutants is considerably more extensive (Figure 6B). Inter-
estingly, the Gsx2 null regions of the LGE, particularly in the
dorsal half, showed ectopic expression of pallial markers. As is
the case in germline Gsx2 mutants (Yun et al., 2001, 2003; Sten-
man et al., 2003b), the expression of the ventral pallial marker
Dbx1 (Figure 5F) was expanded throughout the LGE in Emx1cre
recombined areas of Gsx2 conditional mutants at E12.5. More-
over, a number of the fate-mapped cells colocalized Dbx1 (Fig-
ure 5G). High levels of Pax6 expression, normally observed at
the pallio-subpallial boundary (Figure 5D), were expanded within
the dorsal half of the LGE, specifically in the Gsx2 null areas
(Figure 5E). In germline Gsx2 mutants, the pallial restricted
markers Tbr2 and Tbr1 (Figures 6C and 6G) have both been
shown to be ectopic within the mutant LGE (Yun et al., 2001).
Accordingly, in the Gsx2 conditional mutant LGE, ectopic
Tbr2- and Tbr1-expressing cells were observed in the SVZ and
mantle zone of the dorsal half of the LGE, respectively, and
many of these corresponded to Emx1cre fate-mapped cells
(Figures 6E, 6F, 6I, and 6J). It should be noted that there were
clear Gsx2 null regions in the vLGE (Figure 6B and S4), but
only weak Tbr2 cells (Figures 6E and 6F) and no Tbr1 cells
(Figures 6I and 6J) were observed in this region. These results
indicate that Gsx2 is required cell autonomously to repress
dorsal telencephalic identity in LGE progenitors (predominantly
in the dLGE) until late embryonic stages.
Previous studies have shown that germline deletion of Gsx2
results in reductions in the expression of dLGE and vLGE genes
that eventually lead to abnormalities in the production of olfac-
tory bulb interneurons and striatal projection neurons (Corbin
et al., 2000; Toresson et al., 2000; Toresson and Campbell,
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Figure 5. Generation of a Conditional Allele of Gsx2 and Temporal
Deletion using Emx1cre/+ Mice
(A) Diagram of gene targeting scheme to generate a conditional Gsx2 allele.
(B–I) Representative coronal sections of control and Emx1cre;Gsx2flox/flox (i.e.,
Gsx2 cKO) embryos at E10.5 (B and C), E12.5 (D–G), and E18.5 (H and I). Dele-
tion of floxed Gsx2 allele with Emx1cre/+ mice results in a slight mosaic loss of
Gsx2 in the LGE at E10.5 (C) compared to control (B). Emx1cre/+ recombined
cells were found scattered in the presumptive LGE, as visualized by b-gal
expression from R26R allele, in both the control and cKO (insets of dashed
boxes in B and C, respectively). Two days later (E12.5), the loss of Gsx2 in
cKO embryos is more apparent, manifesting as a clear mosaic deletion pattern
in LGE (compare E to D). The pallial gene Pax6 (D) expands into the Gsx2 null
regions, predominantly in the dorsal half of the Gsx2 cKO LGE (E). The ventral
pallial marker Dbx1 (F) expands throughout the dorsal-ventral aspect of the
LGE in the Gsx2 null areas (G), some of which double label with b-gal from
R26R locus (arrows in F and G). Remarkably, by E18.5 the vast majority of
Gsx2-expressing cells are lost in the cKO LGE (compare I to H).Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 457
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et al., 2004, 2006). Accordingly, dLGE identity as labeled by
Sp8 expression (Figures 6K and 6L and S4C and S4I) is severely
disrupted in the Gsx2 conditional mutants (Figures 6M and 6N
and S4F and S4L). Unlike in the control embryos where Sp8
and b-gal (i.e., fate-mapped cells) are broadly coexpressed
(Figure 6L), little overlap is detected in Gsx2 conditional mutants
(Figure 6N). In contrast to the dLGE, vLGE identity as labeled by
Isl1 expression is not severely affected in the Gsx2 conditional
Gsh2/ß-gal
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Figure 6. Respecification of Gsx2 Null Areas in
the Dorsal Portion of the LGE toward a Pallial
Cell Fate
Confocal images of E14.5 control (A, C, D, G, H, K, L,
O, and P) and Gsx2 cKO (B, E, F, I, J, M, N, Q, and R)
embryos.
(A and B) In control embryos there is significant coloc-
alization of Gsx2 and b-gal (i.e., recombined cells) in
the LGE (A); however, in the cKO embryos Gsx2
expression is dramatically reduced and the b-gal-ex-
pressing cells do not coexpress Gsx2 (B).
(C–J) Tbr2 and Tbr1 are normally expressed in the
developing pallium with a sharp boundary at the pal-
lio-subpallial border (dashed line in C and G). Indeed,
no b-gal-expressing (i.e., recombined) cells in the
LGE were observed to colocalize either of these
factors in the control embryos (D and H). In cKO
embryos, both Tbr2- (E) and Tbr1- (I) expressing cells
are found ectopically in the dorsal portion of the LGE
(the pallio-subpallial boundary is indicated by dashed
lines). A number of these ectopic cells were derived
from Gsx2 mutant cells because they also expressed
b-gal (F and J).
(K–R) Sp8 marks cells in the dLGE (K) and many of
these are observed to coexpress b-gal (L), indicating
that the Emx1cre fate-mapped cells normally give rise
to dLGE cells. Sp8 expression is severely reduced in
the dLGE of Gsx2 cKO embryos (M). Moreover, few,
if any, fate-mapped (i.e., b-gal) cells colocalize Sp8
expression (N). The Isl1 expression domain is relatively
unchanged in Gsx2 cKO LGE (Q) compared to the
control LGE (O). Interestingly, Emx1cre fate-mapped
cells were observed to colocalize Isl1 in both the
control (P) and cKO LGE (R).
mutant (compare Figures S4E and S4K with
S4B and S4H). In fact, we were able to iden-
tify b-gal-positive Emx1 fate-mapped cells
that also express Isl1 in the Gsx2 conditional
mutant LGE (Figure 6R). These findings
suggest that the vLGE may be specified by
Gsx2 in LGE progenitors earlier than E10.5,
since Emx1cre-mediated recombination
starts in the LGE around this time point.
Taken together, these results suggest that
Emx1cre-induced mosaic recombination of
Gsx2 in the LGE severely affects the estab-
lishment of dLGE identity while leaving
vLGE specification largely intact.
To examine dLGE and vLGE derivatives in
Gsx2 conditional mutants, we analyzed
markers of olfactory bulb interneurons and striatal projection
neurons in E18.5 embryos. Germline Gsx2 mutants are known
to have severe defects in striatal development, notably a greater
than 50% reduction in striatal size as observed by Isl1 and FoxP1
expression (Toresson and Campbell, 2001; Waclaw et al., 2004).
Consistent with this result, germline deletion of our Gsx2 condi-
tional allele Gsx2RA/RA (i.e., null allele) results in a 57% reduction
in striatal volume, as marked by FoxP1 expression, compared to
that of control embryos (p < 0.01; n = 3) (compare Figure 7B to458 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.
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Temporal Specification of Neuronal Fate in the LGE7A). On the contrary, striatal volume in the Emx1cre;Gsx2flox/flox
mutants was not significantly different from that in controls
(compare Figure 7C to 7A). In fact, the striatal volume of
Gsx2RA/RA mutants was 53% reduced from that in the Emx1cre
conditional mutants (p < 0.01; n = 3) (compare Figures 7B and
7C). At birth, most striatal projection neurons have been born
but are still undergoing maturation, and thus most mature
markers of these cells are not yet expressed. DARPP-32, which
is ultimately expressed by all striatal projection neurons, only
marks the early-born neurons at birth, which largely belong to
the patch compartment (Foster et al., 1987). The germline
Gsx2 mutants show a disproportionate reduction in DARPP-32
neurons (Corbin et al., 2000; Toresson and Campbell, 2001; Wa-
claw et al., 2004). Emx1cre;Gsx2 conditional mutants (Figure 7C)
exhibited considerably more DARPP-32-positive cells than the
Gsx2RA/RA mutants (Figure 7B), the numbers of which seem to
be only slightly reduced from that seen in controls (compare
Figures 7A and 7C). Together these data support the notion
that the delayed recombination of Gsx2 that is induced by
Emx1cre results in minimal alterations of vLGE specification
or striatal development, at least with respect to what can be
examined at perinatal stages.
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Figure 7. Gsx2Conditional Mutant Embryos
Exhibit More Severe Defects in dLGE Cell
Fate Compared to vLGE Cell Fate
Representative coronal sections of E18.5 control
(A, D, and G), Gsx2 null (B, E, and H), and Gsx2
cKO (C, F, and I) embryos. Striatal development
as marked by the expression of FoxP1 and
DARPP-32 in Gsx2 cKO embryos (C) is dramati-
cally improved compared to the Gsx2 null embryo
striatum (B) and, in fact, is very similar to control
striatum (A). Conversely, Gsx2 cKO embryos
exhibit severe reductions in the olfactory bulb
interneuron markers GAD67 (F) and Meis2 (I)
when compared to control embryos (D and G).
Indeed, the expression of GAD67 and Meis2 in
Gsx2 cKO olfactory bulbs (F and I) is more similar
to that in the Gsx2 null olfactory bulb (E and H).
ac, anterior commissure; GCL, granule cell layer;
GL, glomerular layer.
As mentioned above, germline Gsx2
mutants exhibit defects in dLGE specifi-
cation and an attendant reduction in the
generation of embryonic olfactory bulb
interneurons (Corbin et al., 2000; Tores-
son and Campbell, 2001; Yun et al.,
2001, 2003; Stenman et al., 2003a;
Waclaw et al., 2006). To determine if
Emx1cre;Gsx2flox/flox mutants displayed
defects in embryonic olfactory bulb neu-
rogenesis, we analyzed the expression
of the GABA synthesizing enzyme
GAD67, an established marker of many
embryonic olfactory bulb interneurons
(Kohwi et al., 2007; Kosaka and Kosaka,
2007; Parrish-Aungst et al., 2007). Gsx2
conditional mutants exhibited an 81% reduction in GAD67-posi-
tive cells in the E18.5 olfactory bulb compared to levels in controls
(Figures 7F and 7D) (p < 0.01; n = 3). This reduction was similar to,
but not as severe as, that observed in Gsx2RA/RA mutants that
show a 97% reduction compared to levels in controls (Figures
7E and 7D) (p < 0.01; n = 3). The difference between the
Gsx2RA/RA andEmx1cre conditional mutants is likely due to the re-
maining Gsx2 expression in the dLGE (approximately 20% of
control) that is not recombined by Emx1cre/+ during development
(see Figure 5). In addition to expression of GAD67, we analyzed
expression of Meis2, which is a broad marker of olfactory bulb
interneuron subtypes (Allen et al., 2007). The amount of Meis2
is also clearly reduced in the Gsx2 conditional mutant (Figure 7I)
and Gsx2RA/RA mutant (Figure 7H) compared to that in controls
(Figure 7G). Note that there is almost a complete loss of Meis2
in the forming glomerular layer of both Gsx2 conditional mutants
(Figure 7I) and germline Gsx2 mutants (Figure 7H) compared to
controls (Figure 7G). These results, combined with the analysis
of dLGE identity (i.e., Sp8), indicate that the delayed inactivation
of Gsx2 by Emx1cre significantly affects dLGE development and
the generation of olfactory bulb interneurons in a manner similar
to that observed in the Gsx2RA/RA mutants.Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 459
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Figure 8. Respecification of Olfactory Bulb Interneurons toward Olfactory Bulb Projection Neuron Cell Fate
Confocal images of E18.5 control (A, B, E, and F) and Gsx2 cKO (C, D, G, and H) olfactory bulbs showing Emx1cre fate-mapped cells using the CC-EGFP mice. (A)
Tbr1 is strongly expressed in the mitral cell layer (ML) of the control olfactory bulb with scattered cells in the forming granule cell layer (GCL). Emx1cre fate-mapped
(i.e., EGFP -expressing) cells strongly colocalize Tbr1 in the ML as well as in the GCL (B). In fact, just over half of all fate-mapped cells in the GCL were observed to
be Tbr1 expressing (B0). (C and D) The Gsx2 cKO olfactory bulbs showed increased numbers of Tbr1-positive cells and a loss of the normal laminar organization.
(D) A similar pattern was observed for the fate-mapped EGFP cells in which the proportion of fate-mapped cells that expressed Tbr1 increased dramatically (D0).
(E) Sp8 marks olfactory bulb interneurons in the GCL and GL of control embryos, a significant number of which are observed to be fate mapped by the
Emx1cre mice (F and F0). (G) In Gsx2 cKO embryos, Sp8 is severely depleted in all regions of the olfactory bulb (compare G to E). Contrary to the results with
Tbr1, the fate-mapped mutant olfactory bulb cells were only rarely seen to express Sp8 (H and H0).Previous studies have indicated that the dLGE contributes to
the generation of olfactory bulb interneurons (Stenman et al.,
2003a; Yun et al., 2003; Waclaw et al., 2006). However, recent
studies have suggested that multiple telencephalic regions,
including the pallium, may also produce these interneurons
(Kohwi et al., 2007; Merkle et al., 2007; Ventura and Goldman,
2007; Young et al., 2007). Some of the supporting data for the
pallial contribution has come from fate-mapping Emx1cre cells
in the olfactory bulb. As would be expected, many of the Emx1cre
fate-mapped cells comprise projection neurons (i.e., mitral or
tufted cells) (Gorski et al., 2002); however, a significant number
of recombined cells possess interneuron phenotypes (Kohwi
et al., 2007; Young et al., 2007). To determine the effect of
Gsx2 conditional loss of function in dLGE cells destined for the
olfactory bulb, we crossed the CC-EGFP recombination reporter
mice (Nakamura et al., 2006) onto the Emx1cre;Gsx2flox/flox
mutant background. Tbr1 can be used to mark projection
neurons (mitral and tufted cells) as well as their progenitors in
the olfactory bulb at perinatal time points (Bulfone et al., 1998).
We found that 56.2% ± 6.1% of the Emx1cre fate-mapped cells
located near the progenitor regions of the olfactory bulb were
Tbr1 expressing (i.e., projection neuron identity) (Figures 8B
and 8B0). In contrast, Sp8 can be used to mark many olfactory
bulb interneurons, particularly those expressing calretinin (Wa-
claw et al., 2006), which have also been shown to be Emx1cre
derivatives (Kohwi et al., 2007; Young et al., 2007). Germline460 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.Gsx2 mutants show severe reductions in Sp8-positive cells
within the olfactory bulb (Waclaw et al., 2006). We observed
that 34.9% ± 3.1% of the Emx1cre fate-mapped cells in the
control olfactory bulbs were Sp8 positive (Figures 8F and 8F0).
In the Emx1cre;Gsx2flox/flox mutant bulb, we noticed a dramatic
increase in Tbr1 staining at E18.5 together with a disorganization
in the typical staining pattern for Tbr1 (Figure 8C). Since this
result has not been reported in the germline Gsx2 mutants, we
examined the Gsx2RA/RA mutant olfactory bulbs at E18.5 and
found that they also show increased numbers of Tbr1-positive
cells (Figure S5B). Quantification of the Emx1cre fate-mapped
cells in the conditional mutant olfactory bulb showed that
77.6% ± 1.2% of the EGFP cells expressed Tbr1, which was
a 38% increase from that seen in controls (p < 0.05; n = 3)
(Figures 8D and 8D0). Conversely, Sp8 showed a dramatic reduc-
tion in theGsx2 conditional mutant olfactory bulb (Figure 8G) and
only 6.0% ± 0.2% of the fate-mapped mutant cells contained
Sp8 staining, which was an 82% reduction from that observed
in controls (p < 0.001; n = 3) (Figures 8H and 8H0). Therefore, it
seems that the increase of Tbr1-positive cells in the Emx1cre;
Gsx2flox/flox mutant olfactory bulb occurs at the expense of the
normal generation of Sp8-positive interneurons from Gsx2-
dependent dLGE cells. Moreover, these findings suggest that
the respecified (i.e., ectopic Tbr1 and Tbr2) cells in the condi-
tional mutant dLGE retain the ability to migrate rostrally and
populate the olfactory bulb. Indeed, using Gsx2EGFP mice
Neuron
Temporal Specification of Neuronal Fate in the LGE(Wang et al., 2009) as a short-term fate map of cells derived from
Gsx2-expressing cells, we observed many EGFP and Tbr1 coex-
pressing cells in the olfactory bulb of Gsx2EGFP/RA (i.e., null)
mutants (Figure S5D), unlike the case in Gsx2EGFP/+ embryos
(Figure S5C). Finally, our data question the assumption that
Emx1cre recombination indicates pallial ancestry since we find
that this cre driver significantly recombines Gsx2 in the LGE in
a temporally progressive manner. This leads to a loss of dLGE
specification and ultimately a fate shift in dLGE cells (normally
destined to become olfactory bulb interneurons) toward pallial
fates.
DISCUSSION
Our results show that Gsx2 is capable of directly ventralizing
pallial progenitors and promoting LGE neuronal cell fate specifi-
cation. Interestingly, this homeobox transcription factor appears
to function within a temporal framework to specify predominantly
striatal projection neuron (i.e., vLGE) fates at early stages of LGE
neurogenesis, and subsequently, dLGE fates (i.e., olfactory bulb
interneurons) at later stages of development. Accordingly, our
conditional loss-of-function studies demonstrate that at late
stages of development, Gsx2 is required for the specification of
dLGE fates. Indeed, in the conditional Gsx2 mutants we found
that many of the cells normally fated to become olfactory bulb
interneurons appeared to be respecified toward pallial fates, as
marked by Tbr1 expression. Taken together, our findings indicate
that the dorsal-ventral patterning activities of Gsx2 function
within an independently controlled temporal framework.
Gsx2 and Dorsal-Ventral Patterning
Gsx2 is known to be required for correct dorsal-ventral
patterning in the telencephalon (Corbin et al., 2000; Toresson
et al., 2000; Yun et al., 2001); however, it has been thought to
play an indirect role in this process. In fact, viral misexpression
of Gsx2, which was used to examine Gsx2’s ability to impart
ventral telencephalic identity within early pallial progenitors, did
not support a ventralizing role (Corbin et al., 2000). These authors
reported that neither Ascl1 nor Dlx genes were induced, nor was
Pax6 expression in the dorsal telencephalon reduced by ectopic
Gsx2. The authors did, however, find that the LGE-specific radial
glial marker retinol binding protein (RBP-I) (Toresson et al., 1999)
was moderately upregulated in some of the infected pallial
progenitors. These findings are in stark contrast to those pre-
sented here. It could be that widespread ectopic Gsx2 (as shown
here) is required to ventralize pallial progenitors, essentially rep-
resenting a ‘‘community effect.’’ However, on rare occasions, we
obtained Foxg1tTA;tet-O-Gsx2-IE embryos that exhibited mosaic
expression of Gsx2 that appeared similar to the pattern
observed after viral transductions. The effects of Gsx2 misex-
pression in small clones of EGFP-expressing cells were identical
to those observed in the embryos showing widespread misex-
pression, thus indicating a cell autonomous function for Gsx2
in repressing dorsal identity and promoting LGE specification.
The discrepancy between the present results and those of
Corbin et al. (2000) could be due to downregulation of virally
misexpressed Gsx2 protein prior to the assay points. If this
was the case, the induced RBP-I that Corbin et al. (2000)observed may represent a very sensitive readout of transient
Gsx2 activity, while the regulation of Pax6, Ascl1, and Dlx genes
may require sustained Gsx2 expression.
Although viral misexpression of Gsx2 did not drastically alter
the development of cortical progenitors (Corbin et al., 2000), it
was found to repress Nkx2.1 in the MGE when delivered at
E9.5 (Corbin et al., 2003). This was similar to our results of early
misexpression of Gsx2, where Nkx2.1 was reduced or missing in
the MGE. Interestingly, delayed misexpression of Gsx2 was not
efficient at repressing Nkx2.1 in the MGE, indicating that by
E13.5 MGE progenitors are resistant to Gsx2 influence. Despite
this, the present findings clearly show, using the binary trans-
genic system described here, that ectopic Gsx2 robustly and
reproducibly promotes LGE specification in pallial progenitors
at both early and late time points.
Temporal Control of vLGE versus dLGE Fates by Gsx2
Gsx2 is expressed in a temporally dynamic fashion within the VZ
progenitors of the LGE. At early stages, it is expressed at high
levels in progenitors throughout the presumptive LGE, while at
later stages high-level expression is confined to VZ cells in the
dLGE. The early (E9–E11) high-level expression of Gsx2 corre-
lates with the appearance of Isl1 cells throughout most of
the LGE with limited numbers of Sp8-expressing cells in the
dorsal-most region. This is not the case at later stages (E12
onward), when only Sp8 cells are found in close association
with high-level Gsx2-expressing LGE (i.e., dLGE) cells. This
suggests that Gsx2 can specify both vLGE and dLGE at early
stages of LGE neurogenesis; however, vLGE specification
appears to be favored. Our early misexpression data support
this notion. In contrast, high levels of Gsx2 at later stages (i.e.,
E12 onward) may exclusively promote dLGE fates. Indeed,
when Gsx2 misexpression is delayed by Dox treatment to
around E13, only dLGE specification is observed. Moreover, in
the ventral telencephalon, this appears to be at the expense of
the vLGE (at least its most dorsal portion). These results corre-
spond well with the fact that striatal projection neurons
commence neurogenesis at an earlier time point than the olfac-
tory bulb interneurons (Bayer and Altman, 2004).
Previous studies using germline Gsx2 mutants have shown
that this factor is required for the correct development of both
the striatal projection neurons and olfactory bulb interneurons
(Corbin et al., 2000; Toresson et al., 2000; Toresson and Camp-
bell, 2001; Yun et al., 2001, 2003). The fact that delayed inactiva-
tion of Gsx2 using Emx1cre preserves striatal specification
indicates that correct striatal development depends largely on
early (i.e., pre-E10.5) Gsx2 expression. Conversely, dLGE and
olfactory bulb interneuron development requires Gsx2 function
at least until birth. Taken together, our gain-of-function and
loss-of-function results suggest that vLGE fate is specified
earlier than dLGE fate and that this specification occurs in a
sequential manner. This does not appear to be the case in the
developing spinal cord, where Gsx1/2 are required for the normal
production of both early- and late-generated excitatory interneu-
rons that share similar transcription factor profiles (Mizuguchi
et al., 2006). Thus, our results reveal a specific role for Gsx2 in
the temporal production of molecularly distinct neuronal
subtypes from LGE progenitors.Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc. 461
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Temporal Specification of Neuronal Fate in the LGEGiven the protracted period of neurogenesis in the developing
telencephalon, it is not surprising that temporally regulated
mechanisms would also be involved in the generation of
neuronal diversity within this brain region. In fact, previous trans-
plantation studies have demonstrated a progressive restriction
in the fate potential of cortical progenitors. Those transplanted
from early stages are capable of generating neurons that popu-
late both the deep and superficial cortical layers (McConnell,
1988), while the later stage progenitors are limited to populating
the superficial layers, even if back-transplanted to an earlier
cortical environment (Frantz and McConnell, 1996; Desai and
McConnell, 2000). A likely explanation for this finding is that
the molecular nature of telencephalic progenitors changes over
time and that this constrains fate specification accordingly. In
this respect, Hanashima et al. (2004) previously investigated
the role of Foxg1 in the temporal production of different cortical
neuron subtypes. They found that Foxg1 suppresses the gener-
ation of Cajal-Retzius neurons, the earliest cell type generated in
the cerebral cortex. Moreover, these authors demonstrated that
conditional inactivation of Foxg1 in progenitors that normally
produce deep layer cortical neurons results in the production
of Cajal-Retzius neurons. A subsequent study by Muzio and Mal-
lamaci (2005) suggested that Foxg1 may regulate areal
patterning and, through suppression of Cajal-Retzius neurogen-
esis in most of the pallium, restrict the production of these early-
born neurons to the dorsal medial telencephalon. Cortical
progenitors isolated in vitro have recently been shown to follow
the same schedule of neuron generation as their in vivo counter-
parts, indicating that the factors responsible for progressive
restriction in developmental potential are cell intrinsic (Shen
et al., 2006). Furthermore, these authors demonstrated that
knockdown of Foxg1 in midgestation (e.g., E12) cortical progen-
itors actually appeared to reset the timing of neuron generation
such that early fates (i.e., Cajal-Retzius neurons) were first gener-
ated followed by later cortical fates. Interestingly, late-stage
cortical progenitors (e.g., E15) were not reverted in their develop-
mental potential by the knockdown of Foxg1 (Shen et al., 2006).
Thus Foxg1 plays an important role in restricting the develop-
mental potential of cortical progenitors, specifically by repres-
sing the earliest cortical neuron fate. However, factors that
restrict the fate of cortical progenitors at later embryonic stages
have yet to be identified.
Although evidence for the temporal restriction of develop-
mental potential has been demonstrated for dorsal telencephalic
progenitors, our genetic data indicate that similar restrictions
may also occur in the ventral telencephalon. Importantly, the
response of telencephalic progenitors to misexpressed Gsx2,
at early versus late developmental stages, was similar regardless
of their location in the pallium or LGE. This suggests that similar
temporal patterning mechanisms may regulate the progressive
restriction of developmental potential in both pallial and LGE
progenitors. It may be that in order to specify vLGE fates,
Gsx2 needs to cooperate with a factor or factors that are
restricted in their telencephalic expression to early time points.
In this way, downregulation of such a factor or factors at later
stages would limit Gsx2 to specifying dLGE fates exclusively.
At present, the identity of such a factor or factors are unknown.
Therefore, it seems important to perform molecular profiling462 Neuron 63, 451–465, August 27, 2009 ª2009 Elsevier Inc.studies on telencephalic progenitors, over time, in order to iden-
tify candidate factors involved in regulating this process. Another
mechanism that could regulate progressive restriction in devel-
opmental potential within pallial and LGE progenitors is cell cycle
length, as suggested previously (Shen et al., 2006). In fact, it
seems that the cell cycle length of dorsal telencephalic progen-
itors increases as corticogenesis proceeds, and that this
increase is rather specific to G1 (Caviness et al., 2003; Calegari
et al., 2005). Thus it could be that the duration of Gsx2 activity
during G1 is fundamental to its role in specifying dLGE versus
vLGE at different stages of development. Finally, it is possible
that progressive restriction in developmental potential is also
regulated in SVZ progenitors downstream of Gsx2 such that
the induction of Sp8 leads to a repression of Isl1 and thus
vLGE identity, or vice versa. We are currently performing gain-
of-function studies to address this possibility.
Ventral Recombination by Emx1cre
The conditional mutant analysis shown here was facilitated by
the Emx1cre mice (Gorski et al., 2002). These mice have been
widely used to recombine floxed alleles within pallial progenitors;
however, in their initial characterization the authors noted
recombination also within scattered cells of the LGE (Gorski
et al., 2002). Furthermore, they found recombined cells within
interneuron layers of the olfactory bulb as well as dispersed cells
in the striatum. The Emx1cre-derived cells in the striatum
expressed the calcium binding protein calbindin (which marks
the projection neurons of the matrix; Gerfen et al., 1987), but
not markers of striatal interneuron subtypes. The existence of
Emx1cre recombined cells in the striatum and interneuron layers
of the olfactory bulb has recently been used to argue for a pallial
contribution to ventral telencephalic neuronal diversity, particu-
larly within the striatal projection neuron and olfactory bulb inter-
neuron populations (Willaime-Morawek et al., 2006; Kohwi et al.,
2007; Young et al., 2007; Willaime-Morawek and van der Kooy,
2008). While our data do not exclude this possibility, they
support a simpler explanation whereby Emx1cre is expressed in
LGE progenitors and, by virtue of this, labels significant numbers
of striatal projection neurons and olfactory bulb interneurons.
Indeed, we show recombination in the presumptive LGE begin-
ning as early as E10.5, commensurate with a slight reduction
of Gsx2. By E12.5, large portions of the Gsx2 expression domain
in the LGE are recombined, and surprisingly, at late stages,
nearly 80% of the Gsx2 cells are gone from the LGE. The kinetics
of this recombination were well suited to our questions concern-
ing temporal constraints on Gsx2 in LGE specification. Indeed,
the delayed recombination of Gsx2 that was facilitated by the
Emx1cre mice revealed that vLGE development was largely
preserved, but that the dLGE specification depends on late
stage Gsx2 expression. Indeed, no significant changes were de-
tected in the striatum of the Emx1cre conditional mutants at birth,
while the reductions in olfactory bulb interneuron markers in
these mutants were reduced to levels similar to that seen in
the germline Gsx2 mutants. The dorsal septum has also been
suggested to give rise to olfactory bulb interneurons at perinatal
stages (Merkle et al., 2007). Interestingly, Gsx2 is expressed in
the dorsal septum and was observed to be recombined in the
Emx1cre conditional mutants (Figure 6B), suggesting that Gsx2
Neuron
Temporal Specification of Neuronal Fate in the LGEmay also be required for septal-derived olfactory bulb inter-
neuron generation.
To trace the mutant cells in the LGE, striatum, and olfactory
bulb, we used the recombination reporters R26R (Mao et al.,
1999) or CC-EGFP (Nakamura et al., 2006) in combination with
the Emx1cre;Gsx2flox/flox alleles. We consistently found that the
fate-mapped cells grossly underrepresent the number of recom-
bined LGE cells (as indicated by the loss of Gsx2 expression in
the mutants). The mutant cells in the dLGE lost the expression
of Sp8 and at the same time upregulated the pallial markers
Pax6, Tbr2, and Tbr1. Surprisingly, Emx1cre fate-mapped,
mutant cells in the vLGE did not appear to change fate, since
they retained expression of Isl1, suggesting that vLGE fate was
specified in these cells prior to cre activity (i.e., before E10.5).
In the conditional mutant olfactory bulb, a dramatic decrease
in Sp8-positive, Emx1cre fate-mapped cells was observed coin-
cident with a near doubling of the number of fate-mapped
mutant cells that express the pallial marker Tbr1. The expansion
of pallial markers into the Gsx2 mutant LGE has previously been
suggested to indicate a respecification toward ventral pallial
fates (Yun et al., 2001, 2003; Stenman et al., 2003b). While
ventral pallial progenitors have been proposed to give rise to
projection neurons of the amygdala and pyramidal cortex (Fer-
nandez et al., 1998; Puelles et al., 1999, 2000; Stenman et al.,
2003c; Hirata et al., 2009), no reports to date suggest that these
progenitors migrate rostrally to populate the olfactory bulb.
Thus, it may be that the respecified (i.e., Tbr1-positive) cells in
the dLGE ofGsx2 conditional mutants retain the ability to migrate
rostrally as they would normally do despite their apparent pallial
respecification.
In summary, we show here that Gsx2 is sufficient to specify
LGE fates in pallial progenitors. Additionally, our results indicate
that Gsx2 functions within an independently regulated temporal
framework to specify vLGE and dLGE neuronal fates at distinct
time points in telencephalic development.
EXPERIMENTAL PROCEDURES
Generation of tetO-Gsx2-IE Mice
tetO-Gsx2-IE mice were generated by pronuclear injection and characterized
as described in the Supplemental Data. Dox was used to repress transgene
expression in Foxg1tTA/+;tetO-Gsx2-IE embryos. Specifically, doxycycline hy-
clate (Sigma) was given to pregnant mice in the drinking water at 0.02 mg/ml
beginning at E7 (morning of vaginal plug was defined as E0.5) and removed
approximately 48 hr later (i.e., E9). This Dox dose was the lowest that we found
to completely repress transgene expression in Foxg1tTA/+;tetO-Gsx2-IE
embryos.
Generation of the Gsx2 Conditional Allele
A conditional allele of Gsx2 was generated by homologous recombination in
W4 ES cells (kindly provided by A. Joyner). Briefly, the floxed allele was
made by flanking the second exon of Gsx2 with loxP sites as described in
the Supplemental Data (Figures 5A and S3). Chimeric mice were generated
from two correctly targeted clones (7-B11 and 7-F3) by the transgenic core
at CCHMC. All experiments were performed on the 7-B11 line.
Animals
b-actin-FLPe (enhanced Flpase) mice, R26R mice, EIIA-cre, and Emxcre mice
were obtained from the Jackson Laboratory (Bar Harbor, ME) and genotyped
following protocols from the Jackson Laboratory. CAG-CAT(CC)-EGFP were
genotyped as described in Nakamura et al., (2006). See Supplemental Datafor genotyping details concerning the Foxg1tTA/+, tetO-Gsx2-IE, and Gsx2flox
mice and embryos. For staging of embryos, the morning of vaginal plug detec-
tion was designated E0.5. Embryos and postnatal brains were fixed overnight
in 4% paraformaldehyde, rinsed thoroughly in PBS, and cryoprotected in 30%
sucrose in PBS before sectioning at 12 mM on a cryostat.
Immunohistochemistry
Immunohistochemical staining was done as previously described in Waclaw
et al. (2006). For details concerning the antibodies used, see Supplemental
Data.
Quantification
Quantification for each experiment was done on three different embryos
of each genotype. GAD67-positive cells in the granule cell layer (GCL) were
counted in three olfactory bulb sections at E18.5 in control embryos, Gsx2
null embryos, and Gsx2 conditional mutant embryos. Striatal size of control
embryos, Gsx2 null embryos, and Gsx2 conditional mutants was determined
by quantifying the FoxP1 expression area using the NIH ImageJ program.
Statistics were performed between control embryos, Gsx2 null embryos,
and Gsx2 conditional mutants using a one-way ANOVA with a Tukey post
hoc test. Gsx2-positive cells in the LGE were counted at 400x magnification.
Each genotype was analyzed at identical rostral and caudal levels. For double
staining quantification of Emx1cre/+ fate-mapped cells (EGFP) and either Sp8-
positive or Tbr1-positive cells, double- and single-labeled cells in the GCL
were counted in two separate areas (400x magnification) of two olfactory
bulb sections for each genotype (at least 100 EGFP-positive cells per embryo).
Statistics were performed between control and Gsx2 conditional mutants
using a Student’s unpaired t test.
SUPPLEMENTAL DATA
Supplemental data for this article include Supplemental Experimental Proce-
dures and five figures and can be found at http://www.cell.com/neuron/
supplemental/S0896-6273(09)00544-3.
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